Novartis AG Cash on Hand 2010-2024 | NVS

Novartis AG cash on hand for the quarter ending September 30, 2024 was $14.020B, a 10.44% increase year-over-year.

  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.
  • Novartis AG cash on hand for 2021 was $28.329B, a 145% increase from 2020.

Novartis AG Cash on Hand 2010-2024 | NVS

  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.
  • Novartis AG cash on hand for 2021 was $28.329B, a 145% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B